EMA
approval
· 2018-09-21
New medicine for the prevention of migraine
Summary
The EMA announces a new medicine for the prevention of migraine, representing a new option for preventive treatment pending regulatory approval in the EU.
Upgrade for the full analysis, importance score, and drug timeline.